Abstract
Urocortin (UCN) is a 40-amino-acid peptide and a member of the corticotropin-releasing hormone (CRH) family, which includes CRH, urotensin I, sauvagine, UCN2 and UCN3. The biological actions of CRH family peptides are mediated via two types of G-protein-coupled receptors, namely CRH type 1 receptor (CRHR1) and CRH type 2 receptor (CRHR2). The biological effects of these peptides are mediated and modulated not only by CRH receptors but also via a highly conserved CRH-binding protein (CRHBP). Our aim was to investigate the expression of UCN, CRHR1, CRHR2 and CRHBP by immunohistochemistry, Western blot and reverse transcription with the polymerase chain reaction (RT-PCR) in the horse thyroid gland. The results showed that UCN, CRHR1 and CRHR2 were expressed in the thyroid gland, whereas CRHBP was not expressed. Specifically, UCN immunoreactivity (-IR) was found in the thyroid follicular cells, CRHR2-IR in the C-cells and CRHR1-IR in blood vessels. Western blot analysis and RT-PCR experiments confirmed the immunohistochemical data. These results suggest that a regulatory system exists in the mammalian thyroid gland based on UCN, CRHR1 and CRHR2 and that UCN plays a role in the regulation of thyroid physiological functions through a paracrine mechanism.
Similar content being viewed by others
References
Abdelrahman AM, Syyong HT, Tjahjadi AA, Pang CC (2005) Analysis of the mechanism of the vasodepressor effect of urocortin in anesthetized rats. Pharmacology 7:175–179
Ahren B (1989) Effects of calcitonin, katacalcin, and calcitonin gene related peptide on basal and TSH-stimulated thyroid hormone secretion in the mouse. Acta Physiol Scand 135:133–137
Ahren B (1991) Regulatory peptides in the thyroid gland—a review on their localization and function. Acta Endocrinol (Copenh) 124:225–232
Ain KB, Taylor KD, Tofiq S, Venkataraman G (1997) Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82:1857–1862
Arntzenius AB, Smit LJ, Schipper J, Heide D van der, Meinders AE (1991) Inverse relation between iodine intake and thyroid blood flow: color Doppler flow imaging in euthyroid humans. J Clin Endocrinol Metab 75:1051–1055
Asaba M, Makino S, Hashimoto K (1998) Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotrophin-releasing hormone. Brain Res 806:95–103
Baigent SM, Lowry PJ (2000) Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide. J Mol Endocrinol 24:53–63
Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410–414
Behan DP, Linton EA, Lowry PJ (1989) Isolation of the human plasma corticotrophin-releasing factor-binding protein. J Endocrinol 122:23–31
Behan DP, Cepoi D, Fischer WH, Park M, Sutton S, Lowry PJ, Vale WW (1996) Characterization of a sheep brain corticotropin releasing factor binding protein. Brain Res 732:267
Chen R, Lewis KA, Perrin MH, Vale WW (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967–8971
Cortright DN, Nicoletti A, Seasholtz AF (1995) Molecular and biochemical characterization of the mouse brain corticotropin-releasing hormone-binding protein. Mol Cell Endocrinol 111:147–157
De Groef B, Geris KL, Manzano J, Bernal J, Millar RP, Abou-Samra AB, Porter TE, Iwasawa A, Kühn ER, Darras VM (2003a) Involvement of thyrotropin-releasing hormone receptor, somatostatin receptor subtype 2 and corticotropin-releasing hormone receptor type 1 in the control of chicken thyrotropin secretion. Mol Cell Endocrinol 203:33–39
De Groef B, Goris N, Arckens L, Kuhn ER, Darras VM (2003b) Corticotropin-releasing hormone (CRH)-induced thyrotropin release is directly mediated through CRH receptor type 2 on thyrotropes. Endocrinology 144:5537–5544
De Groef B, Van der Geyten S, Darras VM, Kühn ER (2006) Role of corticotropin-releasing hormone as a thyrotropin-releasing factor in non-mammalian vertebrates. Gen Comp Endocrinol 146:62–68
Dermitzaki E, Tsatsanis C, Minas V, Chatzaki E, Charalampopoulos I, Venihaki M, Androulidaki A, Lambropoulou M, Spiess J, Michalodimitrakis E, Gravanis A, Margioris AN (2007) Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals in a CRF receptor type-specific manner. Endocrinology 148:1524–1538
Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier J (1996) Cloning and characterization of human urocortin. Endocrinology 137:3896
Ellis MJ, Livesey JH, Donald RA (1994) Horse plasma corticotrophin-releasing hormone (CRH): characterisation and lack of a late gestational rise or a plasma CRH-binding protein. J Endocrinol 143:455–460
Fekete EM, Zorrilla EP (2007) Physiology, pharmacology and therapeutic relevance of urocortins in mammals: ancient paralogs. Front Neuroendocrinol 28:1–27
Gkonos PJ, Tavianini MA, Liu CC, Roos BA (1989) Thyrotropin releasing hormone gene expression in normal thyroid parafollicular cells. Mol Endocrinol 3:2101–2109
Grunditz T, Sundler F, Håkanson R, Uddman R (1989) Regulatory peptides in the thyroid gland. Adv Exp Med Biol 261:121–149
Hsu SY, Hsueh AJ (2001) Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605–661
Imperatore A, Florio P, Torres PB, Torricelli M, Galleri L, Toti P, Occhini R, Picciolini E, Vale W, Petraglia F (2006) Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. Am J Obstet Gynecol 195:288–295
Ingbar SH, Braverman LE, Taurog A (1986) Hormone synthesis: thyroid iodine metabolism. In: Ingbar SH, Braverman LE (eds) The thyroid. Section B: hormone synthesis and secretion, 5th edn. Lippincott, Philadelphia, pp 53–93
Kageyama K, Sakihara S, Yamashita M, Takahashi K, Kawashima S, Tanabe J, Tsutaya S, Yasujima M, Suda T (2008) A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins. Am J Med Sci 335:398–402
Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J (2000) Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24:415–419
Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG, Kangawa K, Grossman AB (2001) The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 86:881–887
Kühn ER, Geris KL, Geyten S van der, Mol KA, Darras VM (1998) Inhibition and activation of the thyroidal axis by the adrenal axis in vertebrates. Comp Biochem Physiol A Mol Integr Physiol 120:169–174
Latchman DS (2002) Urocortin. Int J Biochem Cell Biol 34:907–910
Lee S, Braden B, Kang SS, Rivier C (2011) Urocortins are present in the rat testis. Neuropeptides 45:131–137
Lewis K, Li C, Perrin MH, Blount A, Kunitabe K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001) Identification of urocortin III, an additional member of the corticotrophin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98:7570–7575
Lubomirov LT, Gagov H, Petkova-Kirova P, Duridanova D, Kalentchuk VU, Schubert R (2001) Urocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calcium. Br J Pharmacol 134:1564–1570
Lubomirov LT, Reimann K, Metzler D, Hasse V, Stehle R, Ito M, Hartshorne DJ, Gagov H, Pfitzer G, Schubert R (2006) Urocortin-induced decrease in Ca2+ sensitivity of contraction in mouse tail arteries is attributable to cAMP-dependent dephosphorylation of MYPT1 and activation of myosin light chain phosphatase. Circ Res 98:1159–1167
Martín-Lacave I, Borrero MJ, Utrilla JC, Fernández-Santos JM, Miguel M de, Morillo J, Guerrero JM, García-Marín R, Conde E (2009) C cells evolve at the same rhythm as follicular cells when thyroidal status changes in rats. J Anat 214:301–309
Morillo-Bernal JM, Fernández-Santos JM, Utrilla JC, Miguel M de, García-Marín R, Martín-Lacave I (2009) Functional expression of the thyrotropin receptor in C cells: new insights into their involvement in the hypothalamic-pituitary-thyroid axis. J Anat 215:150–158
Morillo-Bernal JM, Fernández-Santos JM, Miguel M de, García-Marín R, Gordillo-Martínez F, Díaz-Parrado E, Utrilla JC, Martín-Lacave I (2011) Ghrelin potentiates TSH-induced expression of the thyroid tissue-specific genes thyroglobulin, thyroperoxidase and sodium-iodine symporter, in rat PC-Cl3 Cells. Peptides 32:2333–2339
Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, Hongo M, Oki Y, Sasano H (2001) Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries. J Clin Endocrinol Metab 86:1362–1369
Oki Y, Sasano H (2004) Localization and physiological roles of urocortin. Peptides 25:1745–1749
Orth DN, Mount CD (1987) Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma. Biochem Biophys Res Commun 143:411–417
Perrin MH, Donaldson CJ, Chen R, Lewis KA, Vale WW (1993) Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. Endocrinology 133:3058–3061
Perrin MH, Grace CR, Riek R, Vale WW (2006) The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors. Ann N Y Acad Sci 1070:105–119
Peto CA, Arias C, Vale WW, Sawchenko PE (1999) Ultrastructural localization of the corticotropin-releasing factor-binding protein in rat brain and pituitary. J Comp Neurol 413:241–254
Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW (1991) Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349:423–426
Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW (1992) The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc Natl Acad Sci USA 89:4192–4196
Raghay K, García-Caballero T, Nogueiras R, Morel G, Beiras A, Diéguez C, Gallego R (2006) Ghrelin localization in rat and human thyroid and parathyroid glands and tumours. Histochem Cell Biol 125:239–246
Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843–2848
Saruta M, Takahashi K, Suzuki T, Fukuda T, Torii A, Sasano H (2005) Urocortin 3/stresscopin in human colon: possible modulators of gastyrointestinal function during stressful condition. Peptides 26:1196–1206
Scopa CD, Mastorakos G, Friedman TC, Melachrinou M, Merino MJ, Chrousos GP (1994) Presence of immunoreactive corticotrophin releasing hormone in thyroid lesions. Am J Pathol 145:1159–1167
Seasholtz AF, Valverde RA, Denver RJ (2002) Corticotropin-releasing hormone-binding protein: biochemistry and function from fishes to mammals. J Endocrinol 175:89–97
Squillacioti C, De Luca A, Liguori G, Paino S, Mirabella N (2011) Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland. Gen Comp Endocrinol 172:416–422
Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J, Vale WW (1995) Ligand requirements of the human corticotropin-releasing factor-binding protein. Endocrinology 36:1097–1102
Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T (2004) Expression of urocortin III/stresscopin in human heart and kidney. J Clin Endocrinol Metab 89:1897–1903
Tamir H, Hsiung SC, Yu PY, Liu KP, Adlersberg M, Nunez EA (1992) Serotonergic signaling between thyroid cells: protein kinase C and 5-HT2 receptors in the secretion and action of serotonin. Synapse 12:155–168
Tamir H, Hsiung SC, Liu KP, Blakely RD, Russo AF, Clark MS, Nunez EA, Gershon MD (1996) Expression and development of a functional plasmalemmal 5-hydroxytryptamine transporter by thyroid follicular cells. Endocrinology 137:4475–4486
Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Sawchenko PE, Vale WW (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotrophin-releasing factor. Nature 378:287–292
Venkatasubramanian S, Newby DE, Lang NN (2010) Urocortins in heart failure. Biochem Pharmacol 80:289–296
Vita N, Laurent P, Lefort S, Chalon P, Lelias JM, Kaghad M, Le Fur G, Caput D, Ferrara P (1995) Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett 335:1–5
Yamauchi N, Otagiri A, Nemoto T, Sekino A, Oono H, Kato I, Yanaihara C, Shibasaki T (2005) Distribution of urocortin 2 in various tissues of the rat. J Neuroendocrinol 17:656–663
Yang LZ, Tovote P, Rayner M, Kockskamper J, Pieske B, Spiess J (2010) Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart. Eur J Pharmacol 632:1–6
Zerek-Melen G, Sewerynek E, Szkudlinski M, Lewinski A, Krotewicz M, Fryczak J, Pawlikowski M (1989) Suppressing effect of cysteamine on the TSH-stimulated mitotic activity of the rat thyroid follicular cells in vivo. Neuropeptides 13:171–174
Author information
Authors and Affiliations
Corresponding author
Additional information
Caterina Squillacioti and Adriana De Luca contributed equally to this work
Rights and permissions
About this article
Cite this article
Squillacioti, C., De Luca, A., Alì, S. et al. Expression of urocortin and corticotropin-releasing hormone receptors in the horse thyroid gland. Cell Tissue Res 350, 45–53 (2012). https://doi.org/10.1007/s00441-012-1450-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-012-1450-4